immune checkpoint

Evernorth: 3 Actionable Insights To Help Health Plans Improve Cancer Care

Immune checkpoint inhibitors are effective cancer treatments, but are expensive. Understanding the least-costly settings for administering treatments, leveraging genomic testing and following evidence-based guidelines can help health plans optimize cancer care, according to Evernorth Research Institute.

By Marissa Plescia

BioPharma

Arch Oncology raises $50M in Series B round for Phase I CD47-targeting antibody

The company joins a small but growing list of firms developing drugs targeting CD47, the "don't eat me" immune checkpoint. Another company, further ahead in development, is Forty Seven.

By Alaric DeArment